Article ID: | iaor20172262 |
Volume: | 37 |
Issue: | 5 |
Start Page Number: | 930 |
End Page Number: | 942 |
Publication Date: | May 2017 |
Journal: | Risk Analysis |
Authors: | Dobe Christopher, Bonifay Sebastien, Fliege Ralph, Krass Joachim, Mostert Volker, Vosswinkel Renate, Wormuth Matthias |
Keywords: | risk, management, medicine, simulation |
This article reviews the interactions between the REACH (Registration, Evaluation, Authorization and restriction of Chemicals) regulation and the plant protection product regulation for substances used as coformulants in the European Union, and describes generic exposure scenarios developed for their exposure and risk assessment. The REACH exposure scenarios describe the operational conditions and risk management measures used in the risk assessment of a coformulant, and as such these translate as the boundaries of safe use. The generic exposure scenarios are designed to be simple, and closely integrate with REACH use descriptors and customized exposure models. Clustering of application methods and exposure determinants resulted in four generic exposure scenarios, each covering professional workers or consumers, and application of products in liquid, granular form, or applied on seeds. When used in conjunction with appropriate exposure models, the generic exposure scenarios support efficient first‐tier risk assessment of coformulants by utilizing a higher level of abstraction and conservatism than typically used in plant protection product assessments.